THERAPEUTIC GAIN OF CONTINUED, LONG-TERM INFLIXIMAB THERAPY IN CROHN'S DISEASE PATIENTS WITH RESPONSE BUT NON-REMISSION AFTER ONE YEAR OF INFLIXIMAB THERAPY

被引：0
|
作者：
Buhl, Sine
Borghede, Marta K.
Brynskov, Jorn
Steenholdt, Casper
Rasmussen, Maria
Ainsworth, Mark A.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1894
引用
收藏
页码：S623 / S624
页数：2
相关论文
共 50 条
  • [1] Therapeutic gain of continued, long-term infliximab therapy in Crohn's disease patients with response but non-remission after one year of infliximab therapy
    Buhl, S.
    Borghede, M. K.
    Brynskov, J.
    Steenholdt, C.
    Rasmussen, M.
    Ainsworth, M. A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S487 - S488
  • [2] Outcome of continued infliximab therapy in Crohn's disease patients with response but without remission after one year of infliximab - a retrospective cohort study
    Buhl, Sine
    Borghede, Marta Kristina
    Brynskov, Jorn
    Steenholdt, Casper
    Rasmussen, Maria
    Ainsworth, Mark Andrew
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (08) : 930 - 937
  • [3] Loss of Response to Long-Term Infliximab Therapy in Children with Crohn's Disease
    Gouldthorpe, Oliver
    Catto-Smith, Anthony G.
    Alex, George
    Simpson, Di
    PHARMACEUTICALS, 2013, 6 (10): : 1322 - 1334
  • [4] Long-Term Outcome of Patients With Crohn's Disease Who Discontinued Infliximab Therapy Upon Clinical Remission
    Papamichael, Konstantinos
    Casteele, Niels Vande
    Gils, Ann
    Tops, Sophie
    Hauenstein, Scott
    Singh, Sharat
    Princen, Fred
    Van Assche, Gert
    Rutgeerts, Paul
    Vermeire, Severine
    Ferrante, Marc
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (06) : 1103 - 1110
  • [5] Long-term response rates to infliximab therapy for Crohn's disease in an outpatient cohort
    Teshima, Christopher W.
    Thompson, Adrienne
    Dhanoa, LeRose
    Dieleman, Levinus A.
    Fedorak, Richard N.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 23 (05): : 348 - 352
  • [6] THE COURSE OF INFLIXIMAB DISCONTINUATION AFTER LONG-TERM MAINTENANCE THERAPY IN CROHN'S DISEASE
    Armuzzi, A.
    Rizzi, M.
    Monterubbianesi, R.
    Marzo, M.
    Cicala, M.
    Guidi, L.
    Prantera, C.
    Kohn, A.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S135 - S135
  • [7] Long-term outcome of infliximab therapy in pediatric Crohn disease
    Wanty, C.
    Stephenne, X.
    Sokal, E.
    Smets, F.
    ARCHIVES DE PEDIATRIE, 2011, 18 (08): : 863 - 869
  • [8] Long-Term Outcome After Infliximab Withdrawal for Sustained Remission in Crohn's Disease
    Reenaers, Catherine
    Mary, Jean-Yves
    Nachury, Maria
    Bouhnik, Yoram
    Laharie, David
    Allez, Matthieu
    Dupas, Jean-Louis
    Amiot, Aurelien
    Savoye, Guillaume
    Altwegg, Romain
    De Vos, Martine
    Malamut, Georgia
    Boureille, Arnaud
    Flourie, Bernard
    Marteau, Philippe R.
    Vuitton, Lucine
    Coffin, Benoit
    Viennot, Stephanie
    Colombel, Jean-Frederic
    Louis, Edouard
    GASTROENTEROLOGY, 2016, 150 (04) : S72 - S72
  • [9] LONG-TERM OUTCOMES OF INFLIXIMAB THERAPY FOR JAPANESE PATIENTS WITH CROHN'S DISEASE AT DIFFERENT TIMES OF INITIATION OF INFLIXIMAB ADMINISTRATION
    Tanaka, Hiroki
    Sugiyama, Kohei
    Miyakawa, Maki
    Nasuno, Masanao
    Motoya, Satoshi
    GASTROENTEROLOGY, 2019, 156 (06) : S884 - S885
  • [10] Serum infliximab and antibodies to infliximab levels in Crohn's disease and ulcerative colitis patients on long-term maintenance therapy
    Waterman, M.
    Bar Yoseph, H.
    Ungar, B.
    Ben-Horin, S.
    Chowers, Y.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S357 - S357
12345